Clare Cutland to Hepatitis B Vaccines
This is a "connection" page, showing publications Clare Cutland has written about Hepatitis B Vaccines.
Connection Strength
0,263
-
Immunogenicity and safety of an investigational fully liquid hexavalent combination vaccine versus licensed combination vaccines at 6, 10, and 14 weeks of age in healthy South African infants. Pediatr Infect Dis J. 2011 Apr; 30(4):e68-74.
Score: 0,090
-
Immunogenicity and safety of an acellular pertussis, diphtheria, tetanus, inactivated poliovirus, Hib-conjugate combined vaccine (Pentaxim) and monovalent hepatitis B vaccine at 6, 10 and 14 weeks of age in infants in South Africa. S Afr Med J. 2011 Feb; 101(2):126-31.
Score: 0,089
-
High-resolution African HLA resource uncovers HLA-DRB1 expression effects underlying vaccine response. Nat Med. 2024 May; 30(5):1384-1394.
Score: 0,056
-
Antibody persistence and booster vaccination of a fully liquid hexavalent vaccine coadministered with measles/mumps/rubella and varicella vaccines at 15-18 months of age in healthy South African infants. Pediatr Infect Dis J. 2013 Aug; 32(8):889-97.
Score: 0,027